Dostinex
Dostinex is a medicine authorised by Swissmedic under authorisation number 51756. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 June 1995 and the authorisation is valid without a time limit. ATC code G02CB03 places the medicine in the group Other gynecologicals.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Dostinex, Tabletten | B | 28 June 1995 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 2 | Tablette(n) | G02CB03 | 07.03.1. | B |
| 2 | 8 | Tablette(n) | G02CB03 | 07.03.1. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Dostinex authorised in Switzerland?
Yes. Dostinex is authorised by Swissmedic under authorisation number 51756, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Dostinex have?
Dostinex is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Dostinex?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.